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Mark S Pearce1*, Kay D Mann1, Gurmeet Singh2, Belinda Davison2 and Susan M Sayers2Abstract
Background: In this study, we used data from Australia’s Northern Territory to assess differences in self-reported
smoking prevalence between the Indigenous and non-Indigenous populations. We also used urinary cotinine data
to assess the validity of using self-reported smoking data in these populations.
Methods: The Aboriginal Birth Cohort (ABC) is a prospective study of 686 Aboriginal babies born in Darwin
1987–90. The Top End Cohort (TEC) is a study of non-Indigenous adolescents, all born in Darwin 1987–91. In
both studies, participants aged between 16 and 21 years, were asked whether they smoked. Urinary cotinine
measurements were made from samples taken at the same visits.
Results: Self-reported smoking prevalence was 68% in the ABC and 14% in the TEC. Among the self-reported
non-smokers, the median cotinine levels were higher in the ABC (33 ng/ml) than in the TEC (5 ng/ml), with
greater percentages of reported non-smokers in the under 50 ng/ml group in the TEC than in the ABC
Conclusions: Prevalence of smoking was much higher in the ABC than in the TEC. The higher cotinine levels in
ABC non-smokers may reflect an underestimated prevalence, but is also likely to reflect higher levels of passive
smoking. A broader approach encompassing social, cultural and language factors with increased attention to
smoking socialisation factors is required.
Keywords: Cigarette smoking, Validation, Cotinine, Aboriginal Australians, Passive smokingBackground
Tobacco smoking is the single most preventable cause of
ill health and death in Australia and is estimated to be the
cause of 15,000 deaths in the country per year [1].
Although smoking rates are declining currently in both
Indigenous and non-Indigenous people in Australia,
marked discrepancies remain between Indigenous and
non-Indigenous rates and their rates of decline [2]. After
adjusting for differences in the age structures of the two
populations, daily smoking was 2.2 times more common
among Indigenous people aged 15 years or older in 2010
than among their non-Indigenous counterparts (38% and
18%, respectively [3]). Furthermore, a comparison of
trends of smoking prevalence among Indigenous and non-* Correspondence: mark.pearce@ncl.ac.uk
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unless otherwise stated.Indigenous Australian secondary school students showed
that rates declined between 1996 and 2005 for both
groups [4]. However, the rate of decline differed, with a
steady decline across the entire study period for the non-
Indigenous students compared to a decline only between
1999 and 2002 for Indigenous students [4]. The majority
of cigarette smokers begin smoking in childhood or ado-
lescence [5], with smoking initiation usually completed by
25 years of age [6,7]. In order to inform different interven-
tion strategies to further reduce initiation and prevalence
of smoking in young Australians, it is important to explore
the differences in smoking prevalence between adolescent
non-Indigenous and Indigenous Australians.
Smoking behaviours are most often assessed by ques-
tionnaire, which is prone to inaccurate responses and
underestimation of the true prevalence of cigarette
smoking [8-10]. This has prompted a number of studies
to attempt to validate smoking questionnaire responses,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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serum, plasma or urine levels of nicotine [13], cotinine
[13-19] or thiocyanate [11], the bogus pipeline approach
[20], or store turnover of cigarettes, as was done previ-
ously in the context of remote Indigenous Australians
[21]. Among the findings from such studies have been
differences in the validity of self-reported smoking by
sex [10,19] and ethnicity [19]. Therefore, in addition to
assessing whether smoking prevalence differs between
different population groups, it is also crucial to assess
whether differences in reliability also exist in order to
assess the validity of the prevalence estimates.
In this study we used data and samples from two co-
horts, the Indigenous Aboriginal Birth Cohort (ABC)
[22,23] and the non-Indigenous Top End Cohort (TEC)
[24] with two aims; i) to assess smoking prevalence from
self-report questionnaire data and, ii) to assess validity of
self-reported smoking, using urinary measures of cotin-
ine. Both cohorts are based in the Australian Northern
Territory (NT).
Methods
The Life Course Program based at the Menzies School
of Health Research is composed of two distinct, but
complementary, cohorts. The ABC is a prospective study
of 686 Aboriginal babies (a representative samples of the
1238 eligible babies) recruited at Royal Darwin Hospital
between January 1987 and March 1990 to a mother re-
corded as Aboriginal in the Delivery Suite Register [22].
Data used in this analysis were obtained during follow-
up between December 2005 and January 2008, in over
40 different locations in the ‘Top End’ of the NT [23].
The TEC is a study of 195 non-Indigenous adolescents,
age- and sex-matched to the ABC study participants, born
in Darwin between 1987 and 1991 (contemporaneous
interval with the ABC) and still residing in non-remote
locations within the Top End at the time of recruit-
ment [24]. The numbers of non-Indigenous people in
remote areas of the NT are very few and this is largely
a transient population. Recruitment occurred between
November 2007 and September 2009 and involved
young people from secondary and tertiary schools, as
well as those in employment and unemployed. Inclusion
was limited to people born to non-Indigenous mothers
as the ABC study encompassed those people. Both
studies were approved by the Human Research Ethics
Committee (HREC) of the Northern Territory Depart-
ment of Health and the Menzies School of Health Re-
search (ABC reference number 05/26, TEC reference
number 07/20). The ABC study also obtained approval
from the Aboriginal Ethical Sub-committee which has the
power of veto.
The residence of ABC participants was classified as
‘non-remote’ (living within the urban areas of Darwinand its satellite city Palmerston) and ‘remote’ (living in a
rural community with an Aboriginal council, a rural
town, or a town camp). All TEC participants resided in
urban areas of Darwin and its satellite city Palmerston,
hence were all ‘non-remote’.
Both the ABC and TEC underwent a comprehensive
health check with cohort members aged between 16 and
21 years.
Self-reported smoking
For both the ABC and TEC, details on smoking status
(current smoker or non-smoker) were self-reported as
part of a lifestyle questionnaire (Appendix) including
smoking of tobacco and marijuana and consumption of al-
cohol. The questions used were chosen as they had been
developed and used previously in a remote Aboriginal set-
ting [25]. The participants had the choice of answering
the questionnaires on a laptop or a paper version. Partici-
pants, particularly those in remote areas, answered these
questions as they were read out to them by the study
team.
Measurement of cotinine
During the medical examinations, questionnaires were
completed, urine samples were collected and cotinine
levels were measured. A cut-off of 50 ng/ml was used to
verify non-smokers in accordance with previously pub-
lished papers [14,17,19]. Further cut-off points of 170,
550 and 2100 ng/ml, as used by Zielińska-Danch et al.
[17], have been used for descriptive purposes.
Statistical analysis
Prevalence/percentage figures with 95% confidence in-
tervals (95% CI) were calculated and chi-squared tests
for associations between smoking and cohort, sex and
residential region (ABC only) were done using a p-value
less than 0.05 for statistical significance. Urinary cotinine
was treated as a continuous measurement and all other
variables were treated as categorical. Comparisons of
cotinine levels between groups were done using the
Wilcoxon rank-sum test. All statistical analyses were
done using the Stata statistical software package, version
12.0 (StataCorp, College Station, TX).
Results
Self-reported smoking data were available for 407 (197
male) participants of the ABC and for 182 (78 male) of
the TEC. Average age at assessment for those with
smoking data was similar between the cohorts (mean
(sd) was 17.9 (1.13) for the ABC and 18.1 (1.38) for the
TEC). Self-reported smoking prevalence was significantly
different between the cohorts (p < 0.0001), with 68%
prevalence in the ABC and 14% prevalence in the TEC
(Table 1). Prevalence rates were similar for males and
Table 1 Self-reported smoking prevalence by cohort,
sex and, for the ABC only, residential area
Self-reported smoking
n Prevalence 95% CI
ABC
Overall 407 0.68 0.63, 0.72
Men 197 0.69 0.63, 0.76
Women 210 0.67 0.60, 0.73
Remote residence 320 0.69 0.64, 0.75
Non-remote residence 85 0.64 0.54, 0.74
TEC
Overall 182 0.14 0.08, 0.19
Men 78 0.13 0.03, 0.21
Women 104 0.14 0.06, 0.22
95% CI: 95% Confidence Interval.
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0.10, df = 1, p = 0.76 for the TEC) and also for remote
and non-remote residential areas in the ABC (χ2 = 1.06,
df = 1, p = 0.30). Six participants in the ABC (1.5%) and
12 in the TEC used to smoke, but were current non-
smokers. No-one in either cohort reported using nicotine
replacement therapy at the time of the study.
Valid urinary cotinine measurements were available
for 391 of the ABC and 156 of the TEC. Descriptive
summaries of the median cotinine levels by self-
reported smoking status are given in Table 2, by cohort,
sex and, for the ABC only, residential area. Among the
self-reported smokers, the median cotinine levels were
higher in the ABC (1300 ng/ml) than in the TEC
(480 ng/ml), Wilcoxon p < 0.0001. Similarly, median
cotinine levels among self-reported non-smokers were
higher in the ABC (33 ng/ml) than in the TEC (5 ng/
ml), Wilcoxon z = 15.63, p < 0.0001.Table 2 Summaries of urinary cotinine levels (ng/ml) by self-r
only, residential area
Self-reported non-smokers
N Median (IQR) Ran
ABC
All 124 33 (5,975) 5,37
Men 56 19 (9,1120) 5,26
Women 68 54 (10,920) 5,37
Remote 95 150 (12,1250) 5,37
Non-remote 29 7 (5,27) 5,17
TEC
All 132 5 (5,5) 5,53
Men 60 5 (5,5) 5,82
Women 72 5 (5,5) 5,53
IQR: Inter-quartile Range.Of the 124 participants in the ABC that self-reported
non-smoking, 58 (47%) recorded cotinine levels higher
than 50 ng/ml (the cut-off usually used for non-
smokers), while of the 267 self-reported smokers, 17
(6%) had cotinine levels less than 50 ng/ml (Table 3).
In contrast, 129 (98%) of the TEC self-reported non-
smokers had cotinine levels of less than 50 ng/ml, with
the remaining three all under 170 ng/ml. However, in
self-reported smokers (n = 24), 14 had cotinine levels
less than 50 ng/ml, with three of those having the
minimum level (5 ng/ml) recorded. The percentage of
self-reported non-smokers above the 50 ng/ml cut-off
was higher in women than men in the ABC, but very
similar in the TEC. The proportion of self-reported
non-smokers in the ABC remote group with cotinine
levels above the 50 ng/ml cut-off was over three times
that seen in the ABC non-remote group.
Discussion
In this study of adolescents from Australia’s Northern
Territory, we have shown striking differences in preva-
lence of self-reported smoking between the Indigenous
and non- Indigenous cohorts. Among self-reported
smokers, the median urinary cotinine measures were
far greater in the ABC participants than their smoking
counterparts in the TEC. Of those self-reporting that
they did not smoke, nearly half of the ABC cohort had
cotinine levels that suggest considerable exposure to
cigarette smoke, while the percentage in the TEC with
this was negligible.
Self-reported smoking prevalence was 68% in the ABC
and only 14% in the TEC. The difference in prevalence
rates does not appear to be due to residential location,
with similar rates seen in the ABC for both the remote
and non-remote populations. Further, there was little
difference in mean age between the cohorts, ruling ageeported smoking status, sex, cohort and, for the ABC
Self-reported smokers
ge N Median (IQR) Range
80 267 1300 (825,1810) 5,4990
20 130 1375 (870,1910) 5,4990
80 137 1260 (725,1740) 5,4920
80 216 1330 (868,1785) 5,4990
60 51 1200 (650,1920) 5,3180
0 24 480 (17,928) 5,1850
9 950 (760,1350) 14,1560
0 15 72 (10,545) 5,1850
Table 3 Numbers (%) in each urinary cotinine group by self-reported smoking status and cohort, sex and, for the ABC
only, residential area
Urinary cotinine level (ng/ml)
0-50 51-170 171-550 551-2100 2101+
ABC
All Smokers 17 (6) 8 (3) 22 (8) 174 (65) 46 (17)
All Non-Smokers 66 (53) 9 (7) 6 (5) 36 (29) 7 (6)
Men Smokers 6 (5) 3 (2) 10 (8) 84 (64) 27 (21)
Men Non-Smokers 34 (61) 2 (4) 2 (4) 16 (29) 2 (4)
Women Smokers 11 (8) 5 (4) 12 (9) 90 (66) 19 (14)
Women Non-Smokers 32 (47) 7 (10) 4 (6) 20 (29) 5 (7)
Remote Smokers 11 (5) 8 (4) 17 (8) 145 (67) 35 (16)
Remote Non-Smokers 42 (44) 6 (6) 6 (6) 34 (36) 7 (7)
Non-remote Smokers 6 (12) 0 (0) 5 (10) 29 (57) 11 (22)
Non-remote Non-Smokers 24 (83) 3 (10) 0 (0) 2 (7) 0 (0)
TEC
All Smokers 8 (33) 2 (8) 4 (17) 10 (42) 0 (0)
All Non-Smokers 129 (98) 2 (2) 1 (1) 0 (0) 0 (0)
Men Smokers 2 (22) 0 (0) (0) 7 (78) 0 (0)
Men Non-Smokers 58 (97) 2 (3) 0 (0) 0 (0) 0 (0)
Women Smokers 6 (40) 2 (13) 4 (27) 3 (20) 0 (0)
Women Non-Smokers 71 (99) 0 (0) 1 (1) 0 (0) 0 (0)
Percentages do not add up to 100 in all cases due to rounding.
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sistent with a previous study of a sample of Indigenous
Australians in Arnhem Land, NT, which reported that
75% of a sample of 400 individuals aged over 16 years
self-reported smoking [12]. These exceptional smoking
rates in the Indigenous population of the ‘Top End’ of the
NTappear to have changed little over the past twenty years,
with rates consistently over 60% [26].
The use of self-reported smoking surveys in epidemio-
logical studies is a crucial and common method used to
obtain information on a major risk factor for many dis-
eases, in addition to assessing smoking prevalence. How-
ever, it is useful to corroborate self-reported smoking
data using one of a number of biochemical markers [10].
The actual choice of biochemical marker to be used will
often depend on factors other than the scientific validity
of the marker, but more on the feasibility of obtaining
the biological material and how crucial the accurate de-
termination of smoking status is. Measures based on
tests of blood are invasive and are unable to provide an
immediate assessment. Less invasive are urine tests,
which for urinary cotinine can provide an almost imme-
diate measure of smoking status. As a result, urinary co-
tinine is a widely used proxy metabolite for nicotine,
used to distinguish between active and passive or non-
smokers [27].We used a discriminative cut-off of 50 ng/ml, in line
with previous studies [14,17,19]. Among self-reported
smokers, the average urinary cotinine measures were far
greater in the ABC participants than in the TEC. Not
only was there a greater prevalence of smoking in the
ABC, but these results suggest heavier smoking, as well
as a greater exposure to passive smoking. A previous
study of the Aboriginal and Torres Strait Islander people
showed that while rates of heavy smoking had decreased
between 1994 and 2008 in that population, the rates of
light smoking had increased [7]. Regardless, for the ABC
population, the levels of smoking remain relatively high.
Of those self-reporting that they did not smoke,
nearly half of the ABC cohort had cotinine levels that
suggest considerable exposure to cigarette smoke, per-
haps through inaccurate responses to the question-
naire, or due to high levels of passive smoking from
the cigarette smoking of family and others, consistent
with the overall high prevalence of smoking in this
population and setting. This was in contrast to the
TEC where only two percent of ‘non-smokers’ fell into
this category. Gilligan et al. [18] used a cut-point of
250 ng/ml to allow for the high levels of passive smok-
ing in Indigenous households. Even using this much
higher cut-point would still have resulted in 47 (36% of
the ABC self-reported non-smokers) being above the
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TEC member above 250 ng/ml. A previous study of the
validity of self-reported smoking in a remote Aborigi-
nal community also used cotinine, but found good
agreement between the self-report and cotinine mea-
sures [16]. n contrast to that study, the study members
included in the investigation of validity in the ABC
were all young adults, and it is possible that accuracy
of responses to questionnaires may vary with age
group. There does not appear to be a validity issue with
the TEC participants. This is consistent with previous
findings of different levels of validity of self-report
smoking responses between ethnic groups [10]. Differ-
ences in cotinine levels between males and females
may reflect different levels of smoking and passive
smoking, but also including pre-menopausal groups of
women with likely differential cotinine metabolism
[28]. It is also possible that high levels of cotinine in light
smokers may reflect compensatory smoking where individ-
uals smoke fewer cigarettes per day, but draw back harder
and absorb more nicotine per cigarette than a heavier
smoker may [29].
While the differences in smoking rates between the
cohorts may represent socio-economic disadvantage to
some extent, it is also likely that other factors such as
cultural differences in views regarding smoking initiation
play an important role. This includes a long-standing
historical antecedent in the way in which tobacco is cur-
rently viewed by Indigenous communities [30]. For ex-
ample, it became a form of currency when obtaining
payment for labour and for settling disputes [30]. In a
qualitative study of Australian Aboriginal women, young
girls were found to start and continue smoking as a way
of attaining status and asserting their Aboriginal identity
such that it is seen as belonging to the group, rather
than rebelling against it [31]. A more recent study has
also shown family and peer influences play a central role
in smoking uptake with Indigenous youth [32], reporting
high levels of smoking role models and smoking social-
isation practices, consistent with the high nicotine levels
in the non-smokers in our study.
Limitations of this study relate to the recruitment of
the study subjects. The ABC participants were nested
within a birth cohort study and are representative of the
Indigenous population across the Top End of Australia
in that age group. The TEC participants of a similar age
were not recruited at birth and may be seen as a select
group interested in their health and, perhaps, less likely
to be smokers. This could introduce some selection bias,
although it is unlikely to account for the large differ-
ences seen in this study. Further, while the same ques-
tionnaires were used for both populations, the ABC
participants mostly needed these to be read out to them
while the TEC were able to answer the questionswithout assistance. The greater degree of anonymity pro-
vided by self-administration of the questionnaires may
have had a bearing on the truthfulness of the responses
received. This could explain some of the differences in
the two cohorts, but is also unlikely to completely ex-
plain the differences between the populations.
The questionnaire was limited to smoking status of
participants of the ABC and TEC and did not include
any information on family smoking status or environ-
mental exposures. However, a previous study in 2008
has shown that 63% of Aboriginal and Torres Strait
Islander children aged 0–14 years lived in a household
with members who were daily smokers (72% in remote
and 61% in non-remote areas) [33]. The NT has the
worst record in overall tobacco control in Australia and
was awarded the Dirty Ashtray Award for the worst per-
forming jurisdiction in nine of the seventeen years it has
been awarded since 1994 [34]. It was omitted from the
national competition after it ranked last for the fourth
consecutive year in 2009 [34].
Conclusion
While tobacco control in NT has improved since 2009
[34], extra resources are needed in the NT, particularly
to aid reductions in smoking prevalence in the Aborigi-
nal population. Given the large discrepancies in smoking
prevalence between the populations and persistent high
levels of smoking among Indigenous young adults, this
suggests that current tobacco control approaches and
are in need of revision and expansion to tailor to the
needs of the Indigenous population. It is likely that a
broader approach encompassing social, cultural and lan-
guage factors with increased attention to smoking social-
isation factors is required. The cultural and language
knowledge of Indigenous health workers may well be the
key to these interventions [26,35], although improve-
ments in the reach of and access to services, and in the
services themselves is also required.
Appendix
The questions on smoking used in the study.
Do you smoke tobacco?
□ no □ used to □ yes
If yes
How often do you smoke?
□ rarely □ weekly □ daily
How many smokes would you have?
How old were you when you started smoking?
If used to
How old were you when you started smoking?
How old were you when you stopped smoking?
Do you smoke marijuana (dope)?
□ no □ used to □ yes
If yes
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□ rarely □ weekly □ daily
How many smokes would you have?
How old were you when you started smoking?
If used to
How old were you when you started smoking?
How old were you when you stopped smoking?
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